ConductScience.org, home

Paper17560695

Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis.

De Wals P and 5 others. Vaccine, 2007. Cited by 36 papers, by iCite.

Cite this record

ConductScience Library. Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis. Papers, record 17560695. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17560695

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis.
PubMed
Journal
Vaccine
PubMed
Year
2007
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
36
iCite
Relative citation ratio, by iCite
1.22
iCite
Revised in PubMed
2007-07-02
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1De Wals PPhilippe
2Coudeville LLaurent
3Trottier PPierre
4Chevat CCatherine
5Erickson LJLonny J
6Nguyen VHVan Hung

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Immunization, SecondaryMajor topic
Meningococcal InfectionsMajor topic
Meningococcal VaccinesMajor topic
Adolescent
Adult
Aged
Aged, 80 and over
Canada
Child
Child, Preschool
Cost-Benefit Analysis
Humans
Infant
Middle Aged

Source PubMed

Download CSV of topics

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.

PMIDTitleJournalYearIn PapersSource
41345602Modelling the epidemiological impact and cost-effectiveness of possible changes to the meningococcal vaccination schedule for adolescents and young adults in the United States.BMC Public Health2025https://conductscience.org/library/papers/41345602PubMed
39250492Economic evaluation on meningococcal vaccination strategies among children under nine years of age in Zhejiang province, China.PLoS One2024https://conductscience.org/library/papers/39250492PubMed
38348600Cost-effectiveness analysis of vaccination strategies against meningococcal disease for children under nine years of age in China.Hum Vaccin Immunother2024https://conductscience.org/library/papers/38348600PubMed
33631080Cost-effectiveness of meningococcal vaccination of Norwegian teenagers with a quadrivalent ACWY conjugate vaccine.Hum Vaccin Immunother2021https://conductscience.org/library/papers/33631080PubMed
31907760Cost-effectiveness of alternative strategies for vaccination of adolescents against serogroup B IMD with the MenB-FHbp vaccine in Canada.Can J Public Health2020https://conductscience.org/library/papers/31907760PubMed
31885753Epidemiology and Control of Meningococcal Disease in Canada: A Long, Complex, and Unfinished Story.Can J Infect Dis Med Microbiol2019https://conductscience.org/library/papers/31885753PubMed
31754924Economic evaluation of meningococcal vaccines: considerations for the future.Eur J Health Econ2020https://conductscience.org/library/papers/31754924PubMed
31680692Advice for Consideration of Quadrivalent (A, C, Y, W135) Meningococcal Conjugate Vaccine, for use by Provinces and Territories.Can Commun Dis Rep2010https://conductscience.org/library/papers/31680692PubMed
28484344Economic evaluations of vaccines in Canada: a scoping review.Cost Eff Resour Alloc2017https://conductscience.org/library/papers/28484344PubMed
28472165Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada.PLoS One2017https://conductscience.org/library/papers/28472165PubMed
26890128Economic evaluation of vaccines in Canada: A systematic review.Hum Vaccin Immunother2016https://conductscience.org/library/papers/26890128PubMed
26651380Routinely vaccinating adolescents against meningococcus: targeting transmission & disease.Expert Rev Vaccines2016https://conductscience.org/library/papers/26651380PubMed
23741448Meningococcal serogroup A, C, W₁₃₅ and Y conjugated vaccine: a cost-effectiveness analysis in the Netherlands.PLoS One2013https://conductscience.org/library/papers/23741448PubMed
20465314Methodological concerns with economic evaluations of meningococcal vaccines.Pharmacoeconomics2010https://conductscience.org/library/papers/20465314PubMed
20364530Meningococcal serogroup C conjugate vaccination in Canada: how far have we progressed? How far do we have to go?Can J Public Health2010https://conductscience.org/library/papers/20364530PubMed
19908924Cost effectiveness of herpes zoster vaccine in Canada.Pharmacoeconomics2009https://conductscience.org/library/papers/19908924PubMed
17709404Estimating the number needed to vaccinate to prevent diseases and death related to human papillomavirus infection.CMAJ2007https://conductscience.org/library/papers/17709404PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17560695

GET https://conductscience.org/api/papers/v1/17560695/authors